LEADER 01992nam  2200373   450 
001 9910688369403321
005 20230625202629.0
024 7 $a10.5772/intechopen.77856
035   $a(CKB)5400000000045946
035   $a(NjHacI)995400000000045946
035   $a(EXLCZ)995400000000045946
100   $a20230625d2019      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCancer Immunotherapy and Biological Cancer Treatments /$fEdited by Hilal Arnouk
210  1$aLondon :$cIntechOpen,$d2019.
210  4$dİ2019
215   $a1 online resource (112 pages)
311   $a1-78984-366-9 
320   $aIncludes bibliographical references and index.
330   $aIn recent years, biological cancer therapies, including immunotherapy, have moved from the bench to mainstream medical treatments of several types of cancer. The success of these treatments relies on innovative approaches to specifically interfere with molecular targets that are involved in the growth, progression, and spread of malignant cells, or to bypass the tumor evasion of the immune system utilizing the latest advances in cancer vaccine development, formulation, and delivery. This book presents an up-to-date overview of novel cancer biological and immunotherapeutic approaches, including cancer vaccines, mimetic vaccines, monoclonal antibodies, adoptive T-cell transfer, chimeric antigen receptor T- cells, tumor infiltrating lymphocytes, dendritic cells, natural killer cells, immune checkpoint inhibitors, laser ablation, and immune stimulating interstitial laser thermotherapy.
606   $aCancer$xImmunotherapy
615  0$aCancer$xImmunotherapy.
676   $a616.994061
702   $aArnouk$b Hilal
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688369403321
996   $aCancer Immunotherapy and Biological Cancer Treatments$92270914
997   $aUNINA